Starfire Investment Advisers Inc. lessened its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 66.0% during the 4th quarter, Holdings Channel reports. The firm owned 2,022 shares of the healthcare conglomerate’s stock after selling 3,928 shares during the quarter. Starfire Investment Advisers Inc.’s holdings in UnitedHealth Group were worth $446,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently made changes to their positions in the company. Marshall Wace LLP boosted its position in shares of UnitedHealth Group by 441.4% in the second quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock valued at $2,578,000 after acquiring an additional 11,361 shares during the period. American Century Companies Inc. boosted its position in shares of UnitedHealth Group by 16.9% in the second quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock valued at $872,051,000 after acquiring an additional 681,111 shares during the period. KBC Group NV boosted its position in shares of UnitedHealth Group by 4.7% in the third quarter. KBC Group NV now owns 323,799 shares of the healthcare conglomerate’s stock valued at $63,416,000 after acquiring an additional 14,672 shares during the period. DekaBank Deutsche Girozentrale boosted its position in shares of UnitedHealth Group by 2.0% in the third quarter. DekaBank Deutsche Girozentrale now owns 489,647 shares of the healthcare conglomerate’s stock valued at $95,646,000 after acquiring an additional 9,810 shares during the period. Finally, Essex Financial Services Inc. boosted its position in shares of UnitedHealth Group by 12.3% in the second quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock valued at $1,640,000 after acquiring an additional 967 shares during the period. Institutional investors own 86.00% of the company’s stock.
Several equities research analysts have recently weighed in on the company. Deutsche Bank increased their price objective on UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Wells Fargo & Co reissued an “outperform” rating and issued a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Leerink Swann reissued an “outperform” rating on shares of UnitedHealth Group in a research report on Friday, December 1st. Jefferies Group reissued a “buy” rating and issued a $248.00 price objective on shares of UnitedHealth Group in a research report on Friday, December 1st. Finally, Evercore ISI reissued an “outperform” rating and issued a $255.00 price objective (up from $235.00) on shares of UnitedHealth Group in a research report on Friday, January 12th. Two research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $243.22.
In other UnitedHealth Group news, CEO Larry C. Renfro sold 22,598 shares of UnitedHealth Group stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the transaction, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director William C. Ballard, Jr. sold 10,000 shares of UnitedHealth Group stock in a transaction on Tuesday, January 23rd. The shares were sold at an average price of $246.38, for a total value of $2,463,800.00. Following the transaction, the director now directly owns 76,637 shares of the company’s stock, valued at $18,881,824.06. The disclosure for this sale can be found here. Over the last three months, insiders have sold 53,396 shares of company stock valued at $12,262,067. Company insiders own 0.89% of the company’s stock.
UnitedHealth Group Inc (NYSE:UNH) opened at $229.37 on Friday. The stock has a market capitalization of $222,270.00, a price-to-earnings ratio of 24.14, a price-to-earnings-growth ratio of 1.32 and a beta of 0.70. UnitedHealth Group Inc has a twelve month low of $156.49 and a twelve month high of $250.79. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.70 and a current ratio of 0.73.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. The company had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business’s revenue was up 9.5% on a year-over-year basis. During the same period last year, the business earned $2.11 earnings per share. equities research analysts anticipate that UnitedHealth Group Inc will post 12.51 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th will be issued a dividend of $0.75 per share. The ex-dividend date is Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.31%. UnitedHealth Group’s payout ratio is presently 31.58%.
TRADEMARK VIOLATION WARNING: This piece was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/18/starfire-investment-advisers-inc-has-446000-holdings-in-unitedhealth-group-inc-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.